UBS AM’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.3M Buy
2,331,838
+538,501
+30% +$7.69M 0.01% 833
2025
Q1
$18.8M Buy
1,793,337
+76,408
+4% +$802K ﹤0.01% 990
2024
Q4
$20.8M Buy
1,716,929
+206,482
+14% +$2.5M ﹤0.01% 930
2024
Q3
$22.2M Sell
1,510,447
-44,370
-3% -$652K 0.01% 903
2024
Q2
$22.4M Buy
1,554,817
+751,807
+94% +$10.8M 0.01% 826
2024
Q1
$13.1M Buy
803,010
+5,712
+0.7% +$93K ﹤0.01% 914
2023
Q4
$11.9M Buy
797,298
+35,237
+5% +$525K ﹤0.01% 929
2023
Q3
$8.57M Sell
762,061
-1,232,415
-62% -$13.9M ﹤0.01% 1005
2023
Q2
$18.7M Hold
1,994,476
0.01% 783
2023
Q1
$18.7M Buy
1,994,476
+8,779
+0.4% +$82.5K 0.01% 783
2022
Q4
$24.3M Sell
1,985,697
-81,267
-4% -$993K 0.01% 707
2022
Q3
$25.7M Sell
2,066,964
-50,691
-2% -$629K 0.01% 704
2022
Q2
$41.6M Buy
2,117,655
+568,986
+37% +$11.2M 0.02% 585
2022
Q1
$40.4M Sell
1,548,669
-31,622
-2% -$825K 0.02% 664
2021
Q4
$44.8M Buy
1,580,291
+17,297
+1% +$491K 0.02% 686
2021
Q3
$49.8M Sell
1,562,994
-7,833
-0.5% -$250K 0.02% 618
2021
Q2
$54.5M Sell
1,570,827
-779,898
-33% -$27.1M 0.02% 623
2021
Q1
$69.2M Buy
2,350,725
+495,943
+27% +$14.6M 0.03% 528
2020
Q4
$56.9M Sell
1,854,782
-601,800
-24% -$18.5M 0.03% 571
2020
Q3
$68.6M Sell
2,456,582
-335,230
-12% -$9.36M 0.04% 436
2020
Q2
$59.9M Sell
2,791,812
-4,758,092
-63% -$102M 0.04% 441
2020
Q1
$169M Sell
7,549,904
-1,685,616
-18% -$37.7M 0.12% 172
2019
Q4
$272M Buy
9,235,520
+2,194,950
+31% +$64.6M 0.17% 119
2019
Q3
$187M Buy
7,040,570
+1,957,520
+39% +$52.1M 0.13% 174
2019
Q2
$172M Buy
5,083,050
+1,947,153
+62% +$65.8M 0.12% 187
2019
Q1
$101M Buy
3,135,897
+2,678,700
+586% +$85.9M 0.07% 286
2018
Q4
$14.4M Buy
457,197
+405,636
+787% +$12.8M 0.01% 774
2018
Q3
$1.8M Buy
+51,561
New +$1.8M ﹤0.01% 1537